Zulian, V.; Salichos, L.; Taibi, C.; Pauciullo, S.; Dong, L.; D’Offizi, G.; Biliotti, E.; Rianda, A.; Federici, L.; Bibbò, A.;
et al. Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients. Biomedicines 2025, 13, 280.
https://doi.org/10.3390/biomedicines13020280
AMA Style
Zulian V, Salichos L, Taibi C, Pauciullo S, Dong L, D’Offizi G, Biliotti E, Rianda A, Federici L, Bibbò A,
et al. Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients. Biomedicines. 2025; 13(2):280.
https://doi.org/10.3390/biomedicines13020280
Chicago/Turabian Style
Zulian, Verdiana, Leonidas Salichos, Chiara Taibi, Silvia Pauciullo, Levi Dong, Gianpiero D’Offizi, Elisa Biliotti, Alessia Rianda, Luigi Federici, Angela Bibbò,
and et al. 2025. "Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients" Biomedicines 13, no. 2: 280.
https://doi.org/10.3390/biomedicines13020280
APA Style
Zulian, V., Salichos, L., Taibi, C., Pauciullo, S., Dong, L., D’Offizi, G., Biliotti, E., Rianda, A., Federici, L., Bibbò, A., De Sanctis, M., McPhee, F., & Garbuglia, A. R.
(2025). Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients. Biomedicines, 13(2), 280.
https://doi.org/10.3390/biomedicines13020280
